AKTX
Akari Therapeutics
AKTX
AKTX
14 hedge funds and large institutions have $63.5M invested in Akari Therapeutics in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
14
Holders Change
+9
Holders Change %
+180%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
11
Increased
–
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DM
1
Deerfield Management
New York
|
$27.6M |
| 2 |
VM
2
VHCP Management
New York
|
$12.7M |
| 3 |
BBA
3
Baker Bros. Advisors
New York
|
$9.5M |
| 4 |
RCM
4
RA Capital Management
Boston,
Massachusetts
|
$6.33M |
| 5 |
EC
5
EcoR1 Capital
San Francisco,
California
|
$2.42M |
Top Sellers
| 1 |
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
|
$687K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$21K |
| 3 |
AIG
3
American International Group
New York
|
$1K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$0 |
